The present invention relates to certain novel 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan
derivatives useful as inhibitors of matrix metalloproteinase. Pharmaceutical compositions
containing said compounds as well as methods of treating various disease states
responding to inhibition of matrix metalloproteinase are also claimed herein.